CYCS and Parkinson disease: Our findings revealed a significant increment in the values of S100 β in PD-treated rats, as the result of the higher binding capacity of S100β with advanced glycation end products (RAGE) receptor, which enhances the release of cytochrome- c from mitochondria and ROS (Niranjan 2014).